US Patent Issued to MEMORIAL SLOAN-KETTERING CANCER CENTER on March 25 for "Cancer antigen targets and uses thereof" (New York Inventors)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,259,390, issued on March 25, was assigned to MEMORIAL SLOAN-KETTERING CANCER CENTER (New York).

"Cancer antigen targets and uses thereof" was invented by Michel Sadelain (New York) and Fabiana Perna (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "The presently disclosed subject matter provides methods and compositions for treating myeloid disorders (e.g., acute myeloid leukemia (AML)). It relates to immunoresponsive cells bearing antigen recognizing receptors (e.g., chimeric antigen receptors (CARs)) targeting AML-specific antigens."

The patent was filed on Feb. 19, 2020, under Application No. 16/795,346.

*For further information, including ...